Atai Beckley NV (ATAI)

• Market cap: $1.58B
• 1 day: 0.46%
• 5 days: -25.47%
• 1 month: -21.3%
• 3 months: 5.06%
• 6 months: 213.67%
• Year to date: 172.5%
• 1 year: 222.96%
• 5 years: -77.58%
• 10 years: -77.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Employees: 54